Literature DB >> 21056544

C-type lectins do not act as functional receptors for filovirus entry into cells.

Keita Matsuno1, Eri Nakayama, Osamu Noyori, Andrea Marzi, Hideki Ebihara, Tatsuro Irimura, Heinz Feldmann, Ayato Takada.   

Abstract

Cellular C-type lectins have been reported to facilitate filovirus infection by binding to glycans on filovirus glycoprotein (GP). However, it is not clearly known whether interaction between C-type lectins and GP mediates all the steps of virus entry (i.e., attachment, internalization, and membrane fusion). In this study, we generated vesicular stomatitis viruses pseudotyped with mutant GPs that have impaired structures of the putative receptor binding regions and thus reduced ability to infect the monkey kidney cells that are routinely used for virus propagation. We found that infectivities of viruses with the mutant GPs dropped in C-type lectin-expressing cells, parallel with those in the monkey kidney cells, whereas binding activities of these GPs to the C-type lectins were not correlated with the reduced infectivities. These results suggest that C-type lectin-mediated entry of filoviruses requires other cellular molecule(s) that may be involved in virion internalization or membrane fusion.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056544      PMCID: PMC3393133          DOI: 10.1016/j.bbrc.2010.10.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.

Authors:  Jens H Kuhn; Sheli R Radoshitzky; Alexander C Guth; Kelly L Warfield; Wenhui Li; Martin J Vincent; Jonathan S Towner; Stuart T Nichol; Sina Bavari; Hyeryun Choe; M Javad Aman; Michael Farzan
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

3.  Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry.

Authors:  Onesmo M Mpanju; Jonathan S Towner; Jason E Dover; Stuart T Nichol; Carolyn A Wilson
Journal:  Virus Res       Date:  2006-07-12       Impact factor: 3.303

4.  Different potential of C-type lectin-mediated entry between Marburg virus strains.

Authors:  Keita Matsuno; Noriko Kishida; Katsuaki Usami; Manabu Igarashi; Reiko Yoshida; Eri Nakayama; Masayuki Shimojima; Heinz Feldmann; Tatsuro Irimura; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

5.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

6.  Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.

Authors:  Melinda A Brindley; Laura Hughes; Autumn Ruiz; Paul B McCray; Anthony Sanchez; David A Sanders; Wendy Maury
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

7.  The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.

Authors:  Derek Dube; Matthew B Brecher; Sue E Delos; Sean C Rose; Edward W Park; Kathryn L Schornberg; Jens H Kuhn; Judith M White
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

8.  LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus.

Authors:  Thomas Gramberg; Heike Hofmann; Peggy Möller; Patricia F Lalor; Andrea Marzi; Martina Geier; Mandy Krumbiegel; Thomas Winkler; Frank Kirchhoff; David H Adams; Stephan Becker; Jan Münch; Stefan Pöhlmann
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

9.  Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.

Authors:  Andrea Marzi; Peggy Möller; Sheri L Hanna; Thomas Harrer; Jutta Eisemann; Alexander Steinkasserer; Stephan Becker; Frédéric Baribaud; Stefan Pöhlmann
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

10.  Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding.

Authors:  Thomas Gramberg; Elizabeth Soilleux; Tanja Fisch; Patricia F Lalor; Heike Hofmann; Sophie Wheeldon; Andrew Cotterill; Anja Wegele; Thomas Winkler; David H Adams; Stefan Pöhlmann
Journal:  Virology       Date:  2008-02-20       Impact factor: 3.616

View more
  18 in total

1.  Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography.

Authors:  Erin E H Tran; James A Simmons; Alberto Bartesaghi; Charles J Shoemaker; Elizabeth Nelson; Judith M White; Sriram Subramaniam
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

2.  Enhancement of Ebola virus infection by seminal amyloid fibrils.

Authors:  Stephen M Bart; Courtney Cohen; John M Dye; James Shorter; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

3.  Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.

Authors:  Anne-Laure Favier; Evelyne Gout; Olivier Reynard; Olivier Ferraris; Jean-Philippe Kleman; Viktor Volchkov; Christophe Peyrefitte; Nicole M Thielens
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 4.  A new player in the puzzle of filovirus entry.

Authors:  Judith M White; Kathryn L Schornberg
Journal:  Nat Rev Microbiol       Date:  2012-04-11       Impact factor: 60.633

Review 5.  Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.

Authors:  Everardo González-González; Mario Moisés Alvarez; Alan Roberto Márquez-Ipiña; Grissel Trujillo-de Santiago; Luis Mario Rodríguez-Martínez; Nasim Annabi; Ali Khademhosseini
Journal:  Crit Rev Biotechnol       Date:  2015-11-26       Impact factor: 8.429

6.  A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

Authors:  Osvaldo Martinez; Esther Ndungo; Lee Tantral; Emily Happy Miller; Lawrence W Leung; Kartik Chandran; Christopher F Basler
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

7.  Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus.

Authors:  Junki Maruyama; Hiroko Miyamoto; Masahiro Kajihara; Hirohito Ogawa; Ken Maeda; Yoshihiro Sakoda; Reiko Yoshida; Ayato Takada
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

8.  Filovirus tropism: cellular molecules for viral entry.

Authors:  Ayato Takada
Journal:  Front Microbiol       Date:  2012-02-06       Impact factor: 5.640

9.  Cellular factors implicated in filovirus entry.

Authors:  Suchita Bhattacharyya; Thomas J Hope
Journal:  Adv Virol       Date:  2013-01-13

Review 10.  Host cell factors in filovirus entry: novel players, new insights.

Authors:  Heike Hofmann-Winkler; Franziska Kaup; Stefan Pöhlmann
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.